TBX21 and autoimmune disease: In autoimmune disorders, the expansion of ABCs and CD14+ Atypical B cells is significantly higher (64, 65); therefore, conditional targeting of the transcription factor T-bet encoded by TBX21, which is important and sufficient for ABCs formation (66), could be an efficient and novel therapeutic target.